Australia markets closed

XORTX Therapeutics Inc. (XRTX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.9972-0.0728 (-2.37%)
At close: 04:00PM EDT
2.9800 -0.02 (-0.57%)
After hours: 05:40PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
6,655
6,490
669.1064
217.5845
Selling general and administrative
4,674
2,295
1,585
624.4895
Total operating expenses
11,380
9,862
2,862
1,020
Operating income or loss
-11,380
-9,862
-2,862
-1,020
Interest expense
-
0
4.3905
10.5963
Total other income/expenses net
13,844
2,772
1,571
23.0661
Income before tax
2,527
-6,989
-1,296
-1,007
Income from continuing operations
2,527
-6,989
-1,296
-1,007
Net income
2,527
-6,989
-1,296
-1,007
Net income available to common shareholders
2,527
-6,989
-1,296
-1,007
Basic EPS
-3.60
-4.71
-1.20
-1.34
Diluted EPS
-3.60
-4.71
-1.20
-1.34
Basic average shares
1,879
1,480
1,094
740.447
Diluted average shares
1,879
1,480
1,094
740.447